Tier 4 — mechanistic

Modulation of Colitis-associated Colon Tumorigenesis by Baicalein and Betaine

Dong Hwan Kim, Bokyung Sung, Hae Young Chung, Nam Deuk Kim
Journal of cancer prevention 2014 19(3):153-160

Bibliography

PubMed
PMID 25337584
PubMed Central
PMC4189507
DOI
10.15430/JCP.2014.19.3.153
Funding
Funding was not specified in the indexed record or accessible funding metadata.
Competing interests
A competing-interest declaration was not available in the indexed record or accessible disclosure metadata.

Study snapshot

DesignNarrative review
ModelEvidence synthesis; mixed research models
SamplePublished literature; no newly enrolled participant cohort
InterventionReview of betaine-related evidence; no single assigned intervention
DurationEvidence review; source-specific study durations vary
EndpointsBetaine biology; Clinical and mechanistic evidence

What the study showed, in plain terms

Published in 2014, this source examined mechanistic and clinical reviews. Its evidence base was Published literature; no newly enrolled participant cohort. It evaluated Review of betaine-related evidence; no single assigned intervention across Evidence review; source-specific study durations vary.

Reviews experimental effects of baicalein and betaine in inflammation-associated colon tumor models.

Mostly cell and mouse research involving separate compounds; not proof of cancer prevention or treatment in people.

Continue with TMG Data Center

Continue with TMG Supplement: Trimethylglycine Benefits, Uses and Evidence

Key findings

  • Reviews experimental effects of baicalein and betaine in inflammation-associated colon tumor models.
  • The recorded outcome domains were Betaine biology; Clinical and mechanistic evidence.

What this study can and cannot tell us

  • Mostly cell and mouse research involving separate compounds; not proof of cancer prevention or treatment in people.
  • The conclusions inherit the limitations of the underlying studies. A narrative interpretation or guideline recommendation is not a new randomized treatment comparison.
  • Source basis: Accessible full-text extract plus indexed bibliographic data. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 4
Association of choline and betaine levels with cancer incidence and survival: A meta-analysis
Jiyoung Youn et al. · Clinical nutrition (Edinburgh, Scotland) · 2019
Tier 4
Choline and betaine consumption lowers cancer risk: a meta-analysis of epidemiologic studies
Shanwen Sun et al. · Scientific reports · 2016
Tier 4
The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis
Heleen Van Puyvelde et al. · Cancer epidemiology · 2023
Tier 4
Decoding Betaine: A Critical Analysis of Therapeutic Potential Compared with Marketing Hype-A Narrative Review
Grzegorz Nikrandt et al. · The Journal of nutrition · 2024
Tier 4
Beneficial Effects of Betaine: A Comprehensive Review
Madan Kumar Arumugam et al. · Biology · 2021
Tier 4
Betaine in human nutrition
Stuart A S Craig et al. · The American journal of clinical nutrition · 2004

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology